Press release
Ebola Virus Infection Market Future Prospects, Trends, Growth, Key Player SWOT Analysis by 2031 | Ridgeback Biotherapeutics, LP, Merck & Co., Inc & Janssen Global Services.
Ebola Virus Infection Market || 2024-2031
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/ebola-virus-infection-market
The Ebola Virus Infection market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Ebola virus infection is a severe and often fatal illness caused by the Ebola virus, a member of the Filoviridae family. The infection is characterized by sudden onset of fever, severe headache, muscle pain, weakness, fatigue, diarrhea, vomiting, abdominal pain, and unexplained bleeding or bruising. The virus is transmitted through direct contact with bodily fluids of infected individuals, including blood, saliva, sweat, and other secretions, as well as through contaminated surfaces or materials. Ebola outbreaks primarily occur in sub-Saharan Africa and can lead to high mortality rates, making rapid diagnosis and effective containment measures essential. Treatment is mainly supportive, focusing on hydration, pain management, and addressing complications, while experimental antiviral therapies and vaccines are under development to combat the disease.
Key Developments:
✫ On August 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for ERVEBO, allowing its use for the prevention of disease caused by the Zaire ebolavirus in individuals aged 12 months and older. Previously, the vaccine was only approved for those aged 18 years and older. The vaccine's effectiveness when administered alongside antiviral medications, immune globulin (IG), and/or blood or plasma transfusions remains unknown. ERVEBO also has a contraindication for individuals with a history of severe allergic reactions to any vaccine component, including rice protein.
✫ In July 2023, the International AIDS Vaccine Initiative (IAVI) initiated the first human trial of a Sudan Ebola virus vaccine, which is an investigational vesicular stomatitis virus (VSV) vector vaccine donated by Merck and licensed by IAVI. The phase 1 trial is funded by the U.S. Biomedical Advanced Research and Development Authority (BARDA), a part of the Department of Health and Human Services (HHS), which acts as the regulatory sponsor for the vaccine candidate and will oversee its clinical development, including comparisons with another Sudan Ebola vaccine using the same virus vector but produced through a new platform.
Forecast Growth Projected:
The Global Ebola Virus Infection Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Ebola Virus Infection Market:
Ridgeback Biotherapeutics, LP, Merck & Co., Inc., Janssen Global Services, LLC, Regeneron Pharmaceuticals, Inc., KBI Biopharma, Soligenix, Inc., BioCryst Pharmaceuticals, Inc., GlaxoSmithKline plc, GeoVax Labs, Inc.
Segment Covered in the Ebola Virus Infection Market:
By Type: Vaccines, Drugs.
By End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Others.
Regional Analysis:
The global Ebola Virus Infection Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/ebola-virus-infection-market
Regional Analysis:
The global Ebola Virus Infection Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Ebola Virus Infection Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Ebola Virus Infection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Ebola Virus Infection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/ebola-virus-infection-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ebola Virus Infection Market Future Prospects, Trends, Growth, Key Player SWOT Analysis by 2031 | Ridgeback Biotherapeutics, LP, Merck & Co., Inc & Janssen Global Services. here
News-ID: 3667608 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Colombia Probiotic Food Supplement Market to Reach US$ 114.41 Mn by 2035 as Dige …
The Colombia Probiotic Food Supplement Market is valued at US$ 47.18 million in 2025 and is projected to reach US$ 114.41 million by 2035, growing at a CAGR of 9.26% during 2026-2035., driven by increasing consumer awareness regarding digestive health, rising demand for preventive healthcare solutions, and growing adoption of functional nutrition products across all age groups in the country.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/colombia-probiotic-food-supplement-market?sindhuri
Growth…
United States Ashwagandha Supplements Market to Hit US$ 1,577.30 Mn by 2033 as D …
The Global Ashwagandha Supplements Market reached US$ 785.80 million in 2025 and is expected to reach US$ 1,577.30 million in 2033, growing at a CAGR of 9.10% during the forecast period (2026-2033), driven by the increasing consumer preference for herbal and natural wellness products, growing awareness regarding stress management and mental health, and rising demand for plant-based nutritional supplementss across developed and emerging markets.
Download your exclusive sample report today (corporate…
United States Advanced Packaging Semiconductor Market to Hit US$ 46.98 Billion b …
The Global Advanced Packaging Semiconductor Market reached US$ 22.48 billion in 2025 and is projected to witness robust growth by reaching up to US$ 46.98 billion by 2035. The Global Advanced Packaging Semiconductor Market is expected to exhibit a CAGR of 7.8% during the forecast period 2026-2035, driven by rising demand for AI accelerators, high-performance computing (HPC), data center processors, chiplet architectures, and heterogeneous integration technologies across next-generation semiconductor devices.…
United States Next-Gen Cloud 3.0 Infrastructure Market to Hit US$ 408.54 Billion …
The Global Next-Gen Cloud 3.0 Infrastructure Market reached US$ 110.2 billion in 2025 and is projected to witness robust growth by reaching US$ 408.54 billion by 2035. The Global Next-Gen Cloud 3.0 Infrastructure Market is expected to exhibit a CAGR of 14.0% during the forecast period 2026-2035, driven by the rapid adoption of AI workloads, increasing deployment of sovereign cloud architectures, rising demand for low-latency edge computing, and the growing…
More Releases for Ebola
WHO Declares Ebola PHEIC Accelerating Growth in the Ebola Virus Vaccine Market | …
The global Ebola Virus Vaccine market is witnessing steady and strategically important growth as governments, international health organizations, and pharmaceutical companies intensify efforts to prevent, contain, and eliminate Ebola Virus Disease outbreaks. Increasing frequency of viral hemorrhagic fever outbreaks, rising global health security funding, and continuous advancements in vaccine technologies are accelerating the development, stockpiling, and rapid deployment of Ebola vaccines across high-risk regions, particularly in Central and West Africa.
Download…
Ebola Vaccine Market : Recent Discoveries and Innovations
The "Ebola Vaccine Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Ebola Vaccine Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading…
Ebola Vaccine Market Deep Research 2025-2032 | Ebola vaccine market are Merck an …
Latest Qualitative Research Report on the Ebola Vaccine Market Size 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth analysis and…
Ebola Virus Vaccine Market 2022 | Detailed Report
The Ebola Virus Vaccine research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the Ebola…
Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which…
